Minimal residual disease detection by flow cytometry: Can it serve as a predictor of future relapse?
Felgar
R E
RE
University of Rochester Medical Center, Department of Pathology and Laboratory Medicine, 601 Elmwood Avenue, Box 626, Rochester, NY 14642, USA. raymond_felgar@urmc.rochester.edu
D000208:Acute Disease; D000951:Antigens, Neoplasm / Q000032:analysis*; D005434:Flow Cytometry / Q000379:methods*; D006801:Humans; D016130:Immunophenotyping; D007938:Leukemia / Q000276:immunology*; D017493:Leukocyte Common Antigens / Q000032:analysis; D009190:Myelodysplastic Syndromes / Q000276:immunology*; D018365:Neoplasm, Residual; D011237:Predictive Value of Tests; D011379:Prognosis
D000951:Antigens, Neoplasm; D017493:Leukocyte Common Antigens